This is the authors' abstract. We don't add key points for this paper.
A subset of phosphodiesterase 3 (PDE3) inhibitors kills cancer cells that express both PDE3A and SLFN12 by inducing a protein-protein interaction between the two, triggering SLFN12 tRNase activity. Following discovery of the prototypical tool compound,
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lewis et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: